GABAPENTIN
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72865-252 -
Package NDC
72865-252-05 -
Package NDC
72865-252-18 -
Package NDC
72865-252-27 -
Package NDC
72865-252-90 -
Application number
ANDA214956 -
SPL ID
702f8307-681f-440d-9f1d-3d26141a914b -
SPL set ID
618c948d-deee-44e2-98f0-e5232171dd50 -
UNII
6CW7F3G59X -
RxCUI
310430 -
RxCUI
310431 -
RxCUI
310432
What the source publishes
- Labeler
- XLCare Pharmaceuticals, Inc.
- Active ingredients
- gabapentin
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "GABAPENTIN",
"splId": "702f8307-681f-440d-9f1d-3d26141a914b",
"labels": [
{
"setId": "618c948d-deee-44e2-98f0-e5232171dd50",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=618c948d-deee-44e2-98f0-e5232171dd50",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=618c948d-deee-44e2-98f0-e5232171dd50"
}
],
"routes": [
"ORAL"
],
"labeler": "XLCare Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "500 CAPSULE in 1 BOTTLE (72865-252-05)",
"package_ndc": "72865-252-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20210510"
},
{
"sample": false,
"description": "180 CAPSULE in 1 BOTTLE (72865-252-18)",
"package_ndc": "72865-252-18",
"identifierStatus": "well-formed",
"marketing_start_date": "20210510"
},
{
"sample": false,
"description": "270 CAPSULE in 1 BOTTLE (72865-252-27)",
"package_ndc": "72865-252-27",
"identifierStatus": "well-formed",
"marketing_start_date": "20210510"
},
{
"sample": false,
"description": "90 CAPSULE in 1 BOTTLE (72865-252-90)",
"package_ndc": "72865-252-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20210510"
}
],
"productId": "72865-252_702f8307-681f-440d-9f1d-3d26141a914b",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "72865-252",
"deaSchedule": null,
"genericName": "gabapentin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "GABAPENTIN",
"strength": "100 mg/1"
}
],
"applicationNumber": "ANDA214956",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20210510",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486"
],
"upc": [
"0372865253908",
"0372865252185",
"0372865254905",
"0372865254059",
"0372865253274",
"0372865253601",
"0372865253182",
"0372865252901",
"0372865252055",
"0372865254271",
"0372865253304",
"0372865253052",
"0372865252277"
],
"unii": [
"6CW7F3G59X"
],
"rxcui": [
"310430",
"310431",
"310432"
],
"spl_set_id": [
"618c948d-deee-44e2-98f0-e5232171dd50"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"manufacturer_name": [
"XLCare Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72865-252_702f8307-681f-440d-9f1d-3d26141a914b"